Skip to main content
OpenTrials
Completed

NCT Number: NCT01441362

Double-lumen Tube Intubation Technique to Reduce Laryngeal Injuries

The purpose of this study is to devise the method to reduce laryngeal injuries during double-lumen tube intubation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing thoracic surgery that require the placement of left-sided double-lumen tubes

Exclusion criteria

  • Preoperative hoarseness or sore throat
  • History of upper airway diseases
  • Anticipated difficult airway
  • Operation time longer than 6 hours

Treatment and study plan

90 degrees rotation

Procedure

Double-lumen tube intubation with 90 degrees rotation

180 degrees rotation

Procedure

Double-lumen tube intubation with 180 degrees rotation

Primary outcomes

  1. postoperative hoarseness

    Time frame: up to 3 days

Secondary outcomes

  1. postoperative sore throat

    Time frame: up to 3 days

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

A Comparison of Two Methods for Intubation With Double-lumen Endobronchial Tube to Reduce Laryngeal Injuries

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Sep 27, 2011
Registry last updated
Feb 20, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.